| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.39 | 0.07 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |